Showing results (1-10 of 274) with videos related to

Sort By:
Pageof 28
Lancet (London, England)|September 18, 1997
Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer ChronotherapyF Lévi, R Zidani, J L Misset
Annals of the New York Academy of Sciences|January 1, 1991
When should the immune clock be reset? From circadian pharmacodynamics to temporally optimized drug deliveryF Lévi, C Canon, M Dipalma, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
Chronomodulation of chemotherapy against metastatic colorectal cancer. International Organization for Cancer ChronotherapyF Lévi, S Giacchetti, R Adam, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Rhythm alteration in patients with metastatic breast cancer and poor prognostic factorsY Touitou, F Lévi, A Bogdan, et al.
Anti-Cancer Drugs|July 18, 2000
Dramatic tumor response of bulky liver metastases following treatment with CPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patientJ M Gornet, D Azoulay, F Lévi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 1998
Irinotecan-induced immune thrombocytopeniaL Bozec, P Bierling, P Fromont, et al.
Hepato-Gastroenterology|May 31, 2001
Chronotherapy of colorectal cancer metastasesF Lévi, S Giacchetti, R Zidani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinomaF Bertheault-Cvitkovic, F Lévi, S Soussan, et al.
Journal of the National Cancer Institute|June 20, 1990
Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rateJ P Caussanel, F Lévi, S Brienza, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancerF Lévi, A Soussan, R Adam, et al.
Pageof 28